FMO5 and liver cancer: Immunohistochemical and western blot analyses confirmed that ADAM9 is upregulated in human liver cancer cells, and ADAM9 causes reactive oxygen species (ROS) generation through the interaction with NADPH oxidase, promoting the liver cancer cell metastasis and epithelial–mesenchymal transition (EMT) [13,16].